rs12232780

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001387283.1(SMARCA4):​c.2617-321G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.276 in 440,446 control chromosomes in the GnomAD database, including 18,525 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4941 hom., cov: 33)
Exomes 𝑓: 0.30 ( 13584 hom. )

Consequence

SMARCA4
NM_001387283.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.325

Publications

25 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 19-11021404-G-A is Benign according to our data. Variant chr19-11021404-G-A is described in ClinVar as [Benign]. Clinvar id is 1249450.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.2617-321G>A intron_variant Intron 18 of 35 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.2617-321G>A intron_variant Intron 18 of 34 ENST00000344626.10 NP_003063.2 P51532-1A7E2E1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.2617-321G>A intron_variant Intron 18 of 35 NM_001387283.1 ENSP00000495368.1 Q9HBD4
SMARCA4ENST00000344626.10 linkc.2617-321G>A intron_variant Intron 18 of 34 1 NM_003072.5 ENSP00000343896.4 P51532-1
SMARCA4ENST00000643549.1 linkc.2617-321G>A intron_variant Intron 18 of 34 ENSP00000493975.1 A0A2R8Y4P4
SMARCA4ENST00000541122.6 linkc.2617-321G>A intron_variant Intron 19 of 34 5 ENSP00000445036.2 P51532-4
SMARCA4ENST00000643296.1 linkc.2617-321G>A intron_variant Intron 18 of 33 ENSP00000496635.1 P51532-4
SMARCA4ENST00000644737.1 linkc.2617-321G>A intron_variant Intron 18 of 33 ENSP00000495548.1 P51532-4
SMARCA4ENST00000589677.5 linkc.2617-321G>A intron_variant Intron 19 of 34 5 ENSP00000464778.1 P51532-3
SMARCA4ENST00000643995.1 linkc.2029-321G>A intron_variant Intron 15 of 31 ENSP00000496004.1 A0A2R8YGG3
SMARCA4ENST00000644963.1 linkc.1261-321G>A intron_variant Intron 11 of 27 ENSP00000495599.1 A0A2R8YG32
SMARCA4ENST00000644065.1 linkc.1342-321G>A intron_variant Intron 11 of 26 ENSP00000493615.1 A0A2R8Y440
SMARCA4ENST00000642350.1 linkc.1102-321G>A intron_variant Intron 10 of 26 ENSP00000495355.1 A0A2R8Y6N0
SMARCA4ENST00000643857.1 linkc.970-321G>A intron_variant Intron 9 of 24 ENSP00000494159.1 A0A2R8Y526

Frequencies

GnomAD3 genomes
AF:
0.237
AC:
36013
AN:
152066
Hom.:
4943
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0918
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.194
Gnomad ASJ
AF:
0.327
Gnomad EAS
AF:
0.218
Gnomad SAS
AF:
0.345
Gnomad FIN
AF:
0.346
Gnomad MID
AF:
0.326
Gnomad NFE
AF:
0.306
Gnomad OTH
AF:
0.242
GnomAD4 exome
AF:
0.297
AC:
85670
AN:
288262
Hom.:
13584
Cov.:
0
AF XY:
0.305
AC XY:
46840
AN XY:
153512
show subpopulations
African (AFR)
AF:
0.0840
AC:
738
AN:
8784
American (AMR)
AF:
0.179
AC:
3060
AN:
17064
Ashkenazi Jewish (ASJ)
AF:
0.319
AC:
2789
AN:
8730
East Asian (EAS)
AF:
0.209
AC:
3305
AN:
15850
South Asian (SAS)
AF:
0.365
AC:
17109
AN:
46850
European-Finnish (FIN)
AF:
0.340
AC:
4499
AN:
13224
Middle Eastern (MID)
AF:
0.343
AC:
803
AN:
2344
European-Non Finnish (NFE)
AF:
0.306
AC:
48810
AN:
159624
Other (OTH)
AF:
0.289
AC:
4557
AN:
15792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3165
6331
9496
12662
15827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.237
AC:
36013
AN:
152184
Hom.:
4941
Cov.:
33
AF XY:
0.241
AC XY:
17900
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0916
AC:
3807
AN:
41546
American (AMR)
AF:
0.194
AC:
2965
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.327
AC:
1134
AN:
3470
East Asian (EAS)
AF:
0.218
AC:
1129
AN:
5178
South Asian (SAS)
AF:
0.345
AC:
1664
AN:
4826
European-Finnish (FIN)
AF:
0.346
AC:
3667
AN:
10584
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.306
AC:
20786
AN:
67966
Other (OTH)
AF:
0.244
AC:
516
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1387
2774
4161
5548
6935
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
4152
Bravo
AF:
0.218
Asia WGS
AF:
0.266
AC:
928
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.16
DANN
Benign
0.38
PhyloP100
-0.33
PromoterAI
0.024
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12232780; hg19: chr19-11132080; COSMIC: COSV107432317; COSMIC: COSV107432317; API